Clinical Trials on Resectable Pancreatic Adenocarcinoma in Hong Kong

Total 383 results

The University of Hong Kong

Completed

Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Hong Kong
Chinese University of Hong Kong

Recruiting

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

Pancreatic Cancer Non-resectable | Pain Cancer | Tumor Pancreas

Hong Kong
Chinese University of Hong Kong

Terminated

Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures

Pancreatic Cancer | Cholangiocarcinoma

Hong Kong
The University of Hong Kong

Completed

Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

Hepatocellular Carcinoma Non-resectable | Stereotactic Body Radiotherapy

Hong Kong
The University of Hong Kong
Taiho Pharmaceutical Co., Ltd.

Active, not recruiting

TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Pancreas Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.

Pancreatic Cancer | Endoscopic Ultrasound

Hong Kong
Chinese University of Hong Kong

Recruiting

Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy

Pancreatic Fistula | Pancreatectomy

Hong Kong
The University of Hong Kong
Feinstein Institute for Medical Research

Unknown

Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma

Adenocarcinoma of Lung (Disorder)

Hong Kong
Chinese University of Hong Kong

Recruiting

Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions

Pancreas Neoplasm

Hong Kong
Arbele Pty Ltd

Recruiting

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Gastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal Junction

Hong Kong, Australia
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Recruiting

EUS-FNB With MOSE vs EUS-FNA With ROSE (MORE)

Pancreatic Neoplasms

Hong Kong
Chinese University of Hong Kong

Recruiting

EUS-guided RFA for Pancreatic Neoplasms

Pancreatic Neoplasms

Hong Kong
Chinese University of Hong Kong

Terminated

Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer

Pain | Cancer of Pancreas

Hong Kong
Humanity & Health Medical Group Limited
Beijing 302 Hospital; Kindai University Faculty of Medicine

Terminated

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
SoonChunHyang University School of Medicine

Completed

EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent

Acute Cholecystitis | Pancreatic Pseudocyst | Biliary Obstruction | Pancreatic Necrosis

China
Chinese University of Hong Kong

Terminated

Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy (IRE)

Pancreatic Cancer | Hepatic Malignant Tumors

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study (CART)

Pancreatic Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Treatment for Bile Duct Cancer in the Liver

Cholangio Carcinoma

Hong Kong
The University of Hong Kong

Recruiting

EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy

Pain | Pancreatic Neoplasms | Pain Management | Cancer of Pancreas | Cancer-Associated Pain

Hong Kong
NovoCure GmbH
Zai Lab (Shanghai) Co., Ltd.

Unknown

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Gastric Cancer | GastroEsophageal Cancer

Hong Kong
Chinese University of Hong Kong
National University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaborators

Completed

Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial.

Unresectable Malignant Gastric Outlet Obstruction

China
Chinese University of Hong Kong

Terminated

The Patency Period of the New Plastic Anti-reflux Biliary Stent

Pancreatitis | Cholangitis

China
Chinese University of Hong Kong

Terminated

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
The University of Hong Kong

Recruiting

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Hepatocellular Carcinoma | Neoplasm

Hong Kong
The University of Hong Kong

Completed

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Secondary

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC)_Torisel_

Inoperable HCC

Hong Kong
Chinese University of Hong Kong

Terminated

Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
CCTU

Recruiting

Pembrolizumab in Hepatocellular Carcinoma

HCC

Hong Kong
Chinese University of Hong Kong

Recruiting

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

Cancer of Stomach, Adenocarcinoma

Hong Kong
The University of Hong Kong

Unknown

Randomized Trial on Robotic Assisted Resection for Rectal Cancer

Adenocarcinoma | Rectal Cancer

Hong Kong
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

TACE Emulsion Versus Suspension

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Completed

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Unknown

SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Dr Tan-to CHEUNG

Completed

Neoadjuvant Anti-PD1 in HCC

HCC | Hepatocellular Carcinoma | Liver Cancer

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Chronic Liver Disease | Hepatic Carcinoma

Hong Kong

Clinical Trials on Resectable Pancreatic Adenocarcinoma in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations